Home | Publications | Medical Devices place holder
place holder place holder

Medical Devices

China Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2012

Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   70
ISBN Number   not applicable
Product Code   GMD1154
Ask a question about this product?

Price £1,075.00

approximately: $1,603 | €1,281

Summary


China Diabetes Care Devices Investment opportunities Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the China diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in China.

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in China.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in China.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 Diabetes Care Devices
    • 3.2 Glucose Monitoring
      • 3.2.1 Blood Glucose Meter
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 Insulin Jet Injector
      • 3.3.2 Insulin Pen
      • 3.3.3 Insulin Pump
      • 3.3.4 Insulin Syringes
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
      • 4.2.1 Healthcare Personnel Data
      • 4.2.2 Healthcare Facilities Data
    • 4.3 Healthcare Policy
    • 4.4 China Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Registration and Conformity assessment
      • 5.1.3 China Compulsory Certificate (CCC Mark)
      • 5.1.4 Labeling and Packaging
      • 5.1.5 Registration Fee
      • 5.1.6 Registration Period
    • 5.2 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 China Cross Market Comparison
  • 9 Diabetes Care Devices Cross Country Comparison
  • 10 Diabetes Care Devices in China
    • 10.1 Diabetes Care Devices Overall Revenues by Category (2000-2012)
    • 10.2 Diabetes Care Devices Overall Volume by Category (2000-2012)
    • 10.3 Diabetes Care Devices Overall Company Share (2006-2007)
  • 11 Glucose Monitoring in China
    • 11.1 Glucose Monitoring Revenues by Segment (2000-2012)
    • 11.2 Glucose Monitoring Volume by Segment (2000-2012)
    • 11.3 Glucose Monitoring Average Price (2000-2012)
    • 11.4 Glucose Monitoring Distribution Share (2006-2007)
    • 11.5 Glucose Monitoring Company Share (2006-2007)
  • 12 Insulin Delivery in China
    • 12.1 Insulin Delivery Revenues by Segment (2000-2012)
    • 12.2 Insulin Delivery Volume by Segment (2000-2012)
    • 12.3 Insulin Delivery Average Price (2000-2012)
    • 12.4 Insulin Delivery Distribution Share (2006-2007)
    • 12.5 Insulin Delivery Company Share (2006-2007)
  • 13 F. Hoffmann-La Roche Ltd. Company Profile
    • 13.1 Company Overview
    • 13.2 Value Chain Analysis
      • 13.2.1 Manufacturing
      • 13.2.2 Product Development
      • 13.2.3 Sales and Marketing
  • 14 Abbott Laboratories Strategic Analysis Profile
    • 14.1 Company Overview
    • 14.2 Value Chain Analysis
      • 14.2.1 Manufacturing
      • 14.2.2 Product Development
      • 14.2.3 Sales and Marketing
    • 14.3 Abbott Laboratories Pipeline Products
      • 14.3.1 Abbott Laboratories Pipeline Products By Equipment Type
      • 14.3.2 Abbott Laboratories Pipeline Products By Development Stage
      • 14.3.3 Abbott Laboratories Pipeline Products By Therapy Area
      • 14.3.4 Abbott Laboratories Pipeline Products By Clinical Trials
      • 14.3.5 Abbott Laboratories Pipeline Products By News Summary
  • 15 LifeScan, Inc. Company Profile
    • 15.1 Company Overview
    • 15.2 LifeScan, Inc. Pipeline Products
      • 15.2.1 LifeScan, Inc. Pipeline Products by Equipment Type
      • 15.2.2 LifeScan, Inc. Pipeline Products by Development Stage
      • 15.2.3 LifeScan, Inc. Pipeline Products by Therapy Area
      • 15.2.4 LifeScan, Inc. Pipeline Products by News Summary
  • 16 Novo Nordisk A/S Company Profile
    • 16.1 Company Overview
    • 16.2 Novo Nordisk A/S Pipeline Products
      • 16.2.1 Novo Nordisk A/S Pipeline Products by Equipment Type
      • 16.2.2 Novo Nordisk A/S Pipeline Products by Development Stage
      • 16.2.3 Novo Nordisk A/S Pipeline Products by Therapy Area
  • 17 Becton, Dickinson and Company Strategic Analysis Profile
    • 17.1 Company Overview
    • 17.2 Value Chain Analysis
      • 17.2.1 Manufacturing
      • 17.2.2 Product Development
      • 17.2.3 Sales and Marketing
  • 18 Appendix
    • 18.1 Global Markets Direct Research Methodology
    • 18.2 Coverage
    • 18.3 Secondary Research
    • 18.4 Primary Research
    • 18.5 Models
    • 18.6 Forecasts
    • 18.7 Expert Panels
    • 18.8 Currency Conversion
    • 18.9 Contact Us
    • 18.10 Disclaimer
  • LIST OF TABLES
  • 1 List of Tables
    • Table 1: Doctors by Specialty in China, 2003-2007
    • Table 2: Hospital Wards by Specialty in China, 2003 - 2007
    • Table 3: Healthcare Institutions in China, 2000-2004
    • Table 4: Personnel Employed in Healthcare Institutions in China, 2000-2004
    • Table 5: Healthcare Institutions, Hospital Beds and Employed Personnel by Region in China, 2004
    • Table 6: China Healthcare Trade Statistics, 2001-2006
    • Table 7: China, Medical Equipment Market Comparison
    • Table 8: Diabetes Care Devices Market, Country Comparison
    • Table 9: Diabetes Care Devices, China, Category Revenues ($ mn), 2000-2012
    • Table 10: Diabetes Care Devices Market, China, Portfolio Analysis
    • Table 11: Diabetes Care Devices, China, Category Revenues ($ mn), Historic, 2000-2007
    • Table 12: Diabetes Care Devices, China, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 13: Diabetes Care Devices, China, Overall Volume (Units), 2000-2012
    • Table 14: Diabetes Care Devices, China, Overall Volume (Units), Historic, 2000-2007
    • Table 15: Diabetes Care Devices, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 16: Diabetes Care Devices, China, Overall Company Share by Revenue ($ mn), 2006-2007
    • Table 17: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 18: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 19: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2007
    • Table 20: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 21: Glucose Monitoring, China, Average Price ($), Historic, 2000-2007
    • Table 22: Glucose Monitoring, China, Average Price ($), Forecast, 2007-2012
    • Table 23: Glucose Monitoring, China, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 24: Glucose Monitoring, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 25: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 26: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 27: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2000-2007
    • Table 28: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 29: Insulin Delivery, China, Average Price ($), Historic, 2000-2007
    • Table 30: Insulin Delivery, China, Average Price ($), Forecast, 2007-2012
    • Table 31: Insulin Delivery, China, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 32: Insulin Delivery, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 33: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 34: Abbott Laboratories Pipeline Products By Development Stage
    • Table 35: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 36: Abbott Laboratories Pipeline Products By Clinical Trials
    • Table 37: Abbott Laboratories Pipeline Products By News Summaries
    • Table 38: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 39: LifeScan, Inc. Pipeline Products By Development Stage
    • Table 40: LifeScan, Inc. Pipeline Products By Therapy Area
    • Table 41: LifeScan, Inc. Pipeline Products By News Summaries
    • Table 42: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 43: Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 44: Novo Nordisk A/S Pipeline Products By Therapy Area
    • Table 45: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • LIST OF FIGURES
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in China, 2000 - 2005
    • Figure 2: Medical Equipment Registration Process in China, 2007
    • Figure 3: CCC Mark Certification Process in China, 2007
    • Figure 4: China, Medical Equipment Market Comparison, 2007
    • Figure 5: Diabetes Care Devices, Revenues ($ mn) by Country, 2000-2012
    • Figure 6: Diabetes Care Devices Market, Country Comparison
    • Figure 7: Diabetes Care Devices, China, Category Revenues ($ mn), 2000-2012
    • Figure 8: Diabetes Care Devices Market, China, Portfolio Analysis
    • Figure 9: Diabetes Care Devices, China, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 10: Diabetes Care Devices, China, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 11: Diabetes Care Devices, China, Overall Company Share (%), 2007
    • Figure 12: Glucose Monitoring, China, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 13: Glucose Monitoring, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 14: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2000-2007
    • Figure 15: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2007-2012
    • Figure 16: Glucose Monitoring, China, Company Share (%), 2007
    • Figure 17: Insulin Delivery, China, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 18: Insulin Delivery, China, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 19: Insulin Delivery, China, Company Share (%), 2007
    • Figure 20: F. Hoffmann-La Roche Ltd., Value Chain Analysis
    • Figure 21: Abbott Laboratories, Value Chain Analysis
    • Figure 22: Becton, Dickinson and Company, Value Chain Analysis
    • Figure 23: Global Markets Direct Methodology